New study opens door to multipronged attack against skin common cancer
Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is ...
Cancer
Feb 27, 2013 |
5 / 5 (2) |
0
|
New cancer 'vaccine' shows future promise in treating and preventing metastatic cancers
Preclinical, laboratory studies suggest a novel immunotherapy could potentially work like a vaccine against metastatic cancers, according to scientists at Virginia Commonwealth University Massey Cancer Center. Results from ...
Cancer
Feb 27, 2013 |
5 / 5 (1) |
0
|
The brakes of inflammation
In the last few decades, scientists have come to attribute an immunological explanation to many cancers. It is now thought that tumors rise up routinely in the body but that a healthy immune ...
Immunology
Feb 27, 2013 |
4.8 / 5 (6) |
2
Novel combination therapy shuts down escape route, killing glioblastoma tumor cells
Glioblastoma, the most common and lethal form of brain tumor in adults, is challenging to treat because the tumors rapidly become resistant to therapy. As cancer researchers are learning more about the causes of tumor cell ...
Cancer
Feb 26, 2013 |
5 / 5 (1) |
2
|
New research challenges notion of using Herceptin only for HER2-positive breast cancer
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative – and that ...
Cancer
Feb 26, 2013 |
not rated yet |
0
|
Researchers discover protein that may control the spread of cancer
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at ...
Cancer
Feb 26, 2013 |
5 / 5 (1) |
0
Small molecules in the blood might gauge radiation effects after exposure
Ohio State University cancer researchers have identified molecules in the bloodstream that might accurately gauge the likelihood of radiation illness after exposure to ionizing radiation.
Cancer
Feb 25, 2013 |
5 / 5 (1) |
0
|
Researchers find cancer aggression differences in different types of prostate cells
(Medical Xpress)—A research team made up of representatives from several cancer research centers in the United States has found that cancers that develop in the prostate of mice may be either aggressive or sluggish depending ...
Cancer
Feb 25, 2013 |
4.7 / 5 (3) |
0
|
Distinct niches in bone marrow nurture blood stem cells
In research that could one day improve the success of stem cell transplants and chemotherapy, scientists have found that distinct niches exist in bone marrow to nurture different types of blood stem cells.
Medical research
Feb 24, 2013 |
3 / 5 (1) |
0
|
Team finds general mechanism that accelerates tumor development
ICREA professor Raúl Méndez publishes a study in Nature describing how the CPBE1 protein "takes the brakes off" the production of proteins associated with the cell switch from being healthy to tumorous. ...
Cancer
Feb 24, 2013 |
5 / 5 (3) |
0
Scientists find underlying mechanisms behind chronic inflammation-associated diseases
(Medical Xpress)—Inflammatory response plays a major role in both health protection and disease generation. While the symptoms of disease-related inflammatory response have been know, scientists have not ...
Inflammatory disorders
Feb 23, 2013 |
4.8 / 5 (10) |
4
|
US approves new targeted breast cancer drug (Update)
The U.S. Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
Cancer
Feb 22, 2013 |
5 / 5 (1) |
0
Biomarker may identify neuroblastomas with sensitivity to BET bromodomain inhibitors
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors ...
Cancer
Feb 21, 2013 |
not rated yet |
0
'Chemo brain': Study finds fog-like condition related to chemotherapy's effect on new brain cells and rhythms
(Medical Xpress)—It's not unusual for cancer patients being treated with chemotherapy to complain about not being able to think clearly, connect thoughts or concentrate on daily tasks. The complaint – ...
Neuroscience
Feb 21, 2013 |
not rated yet |
1
|
New epigenetic mechanisms for improved cancer therapy
A review article by researchers at Boston University School of Medicine (BUSM) proposes a new epigenetic hypothesis linked to tumor production and novel ideas about what causes progenitor cells to develop into cancer cells. ...
Cancer
Feb 19, 2013 |
5 / 5 (3) |
0
|
